1. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. Issue 5 (May 2022) Authors: Self, Wesley H.; Sandkovsky, Uriel; Reilly, Cavan S.; Vock, David M.; Gottlieb, Robert L.; Mack, Michael; Golden, Kevin; Dishner, Emma; Vekstein, Andrew; Ko, Emily R.; Der, Tatyana; Franzone, John; Almasri, Eyad; Fayed, Mohamed; Filbin, Michael R.; Hibbert, Kathryn A.; Rice, Todd W.; Casey, Jonat... Journal: Lancet infectious diseases Issue: Volume 22:Issue 5(2022) Page Start: 622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Depressive symptoms are frequent among drug users, but not associated with hepatitis C infection. (August 2014) Authors: Madsen, Lone W.; Fabricius, Thilde; Hjerrild, Simon; Hansen, Thomas M.; Mössner, Belinda K.; Birkemose, Inge; Skamling, Merete; Christensen, Peer B. Journal: Scandinavian journal of infectious diseases Issue: Volume 46:Number 8(2014:Aug.) Page Start: 566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗